Mj Biotech, Inc. (BNBI)
| Sector • Technology Industry • Internet Services & Social Media |
| Industry • Internet Services & Social Media |
| Sector • Technology |
The rising company from the Biotechnology & Pharmaceuticals market the BNBI reported the fourth quarter of 2018, results
BNBI announced fourth quarter of 2018 operating profit of $5.761972 millions
Published Nov 30 -0001
Goran Soko / CSIMarket.com Contributer
The Biotechnology & Pharmaceuticals industry insiders continue to analyze the fourth quarter of 2018 numbers. Today those insiders observe operating profit of $5.761972 millions, from the Mj Biotech, Inc., as it hasn't stated any revenue yet, for the own October to December 31 2018 reporting period. The Net income appears to be very well in the most recent quarter. Mj Biotech, Inc. has enhanced net income to $5.353 millions, from $0.000 millions, in the fourth quarter of 2017.
the Biotechnology & Pharmaceuticals company reported shortfall of $-0.84 millions and Revenues of $0.00 millions in the financial year 2018.
Mj Biotech, Inc. announced further break-even in proportion to $-0.04 in the previous financial year, while by 0 % from $0.00 millions a year before.